Evidence map›Paper›PMID 42171554›Full record

ArticleJACC. Case reports2026

Dedicated Transcatheter Valve for Pure Aortic Regurgitation in a Failed Stentless Bioprosthesis.

Silvia Corona, Sebastián Mrad, Remi Kouz, Reda Ibrahim, Marco Julien, Marina Ibrahim, Christine Henri, Louis-Philippe David, Ralph Stephan von Bardeleben, Walid Ben Ali

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Silvia CoronaStructural Heart Valve Center and Cardiac Surgery Department, Montreal Heart Institute, Montreal, Canada. Electronic address: silviacoro89@gmail.com.
Sebastián MradStructural Heart Valve Center and Interventional Cardiology Department, Montreal Heart Institute, Montreal, Canada.
Remi KouzStructural Heart Valve Center and Interventional Cardiology Department, Montreal Heart Institute, Montreal, Canada; Cardiology Division, Hôpital du Sacré-Coeur de Montréal, Montreal, Canada.
Reda IbrahimStructural Heart Valve Center and Interventional Cardiology Department, Montreal Heart Institute, Montreal, Canada.
Marco JulienAnesthesiology Department, Montreal Heart Institute, Montreal, Canada.
Marina IbrahimStructural Heart Valve Center and Cardiac Surgery Department, Montreal Heart Institute, Montreal, Canada.
Christine HenriEchocardiography Department, Montreal Heart Institute, Montreal, Canada.
Louis-Philippe DavidEchocardiography Department, Montreal Heart Institute, Montreal, Canada.
Ralph Stephan von BardelebenStructural Heart Valve Center and Interventional Cardiology Department, Montreal Heart Institute, Montreal, Canada.
Walid Ben AliStructural Heart Valve Center and Cardiac Surgery Department, Montreal Heart Institute, Montreal, Canada. Electronic address: dr.walidbenali@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn 80-year-old man presented with progressive dyspnea due to severe isolated regurgitation of a 29-mm ATS 3f stentless (model 1000) aortic bioprosthesis. Because of his advanced age and multiple severe comorbidities, the Heart Team opted for a valve-in-valve transcatheter aortic valve replacement (TAVR). CASE SUMMARY: Based on preprocedural computed tomography planning, a valve-in-valve TAVR procedure was successfully performed via transfemoral access using a 27-mm JenaValve Trilogy System. DISCUSSION: Although the use of dedicated TAVR devices for the treatment of native aortic regurgitation has been well-described, to our knowledge, there are no existing reports on their use to address regurgitation caused by the structural valve deterioration of a stentless bioprosthesis. TAKE-HOME MESSAGE: Consider a dedicated transcatheter valve to treat pure regurgitation in a failing stentless bioprosthesis.

Indexed as

aortic regurgitationJenaValvestentless bioprosthesisstructural valve degenerationTAVRvalve-in-valve

Identifiers

PMID42171554
PMCPMC13332642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.